Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score?
- PMID: 20117441
- PMCID: PMC2845313
- DOI: 10.1016/j.jacc.2009.08.058
Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score?
Abstract
Objectives: This study was designed to determine whether erectile dysfunction (ED) predicts cardiovascular disease (CVD) beyond traditional risk factors.
Background: Both ED and CVD share pathophysiological mechanisms and often co-occur. It is unknown whether ED improves the prediction of CVD beyond traditional risk factors.
Methods: This was a prospective, population-based study of 1,709 men (of 3,258 eligible) age 40 to 70 years. The ED data were measured by self-report. Subjects were followed for CVD for an average follow-up of 11.7 years. The association between ED and CVD was examined using the Cox proportional hazards regression model. The discriminatory capability of ED was examined using C statistics. The reclassification of CVD risk associated with ED was assessed using a method that quantifies net reclassification improvement.
Results: Of the prospective population, 1,057 men with complete risk factor data who were free of CVD and diabetes at baseline were included. During follow-up, 261 new cases of CVD occurred. We found ED was associated with CVD incidence controlling for age (hazard ratio [HR]: 1.42, 95% confidence interval [CI]: 1.05 to 1.90), age and traditional CVD risk factors (HR: 1.41, 95% CI: 1.05 to 1.90), as well as age and Framingham risk score (HR: 1.40, 95% CI: 1.04 to 1.88). Despite these significant findings, ED did not significantly improve the prediction of CVD incidence beyond traditional risk factors.
Conclusions: Independent of established CVD risk factors, ED is significantly associated with increased CVD incidence. Nonetheless, ED does not improve the prediction of who will and will not develop CVD beyond that offered by traditional risk factors.
Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure: Dr. Rosen reports that he serves as a consultant to Bayer-Schering, Eli Lilly, and Pfizer. Dr. Ganz has reports that he serves as a consultant to GlaxoSmithKline, Genentech, and Pfizer. Dr. Hall is a former employee of and former consultant to GlaxoSmithKline, but has no equity interest in GlaxoSmithKline. All other authors report no conflict of interest.
Similar articles
-
Sexual activity, erectile dysfunction, and incident cardiovascular events.Am J Cardiol. 2010 Jan 15;105(2):192-7. doi: 10.1016/j.amjcard.2009.08.671. Am J Cardiol. 2010. PMID: 20102917 Free PMC article.
-
Changes in erectile dysfunction over time in relation to Framingham cardiovascular risk in the Boston Area Community Health (BACH) Survey.J Sex Med. 2015 Jan;12(1):100-8. doi: 10.1111/jsm.12715. Epub 2014 Oct 8. J Sex Med. 2015. PMID: 25293632 Free PMC article.
-
Erectile dysfunction and mortality.J Sex Med. 2009 Sep;6(9):2445-54. doi: 10.1111/j.1743-6109.2009.01354.x. Epub 2009 Jun 15. J Sex Med. 2009. PMID: 19538544 Free PMC article.
-
Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies.J Am Coll Cardiol. 2011 Sep 20;58(13):1378-85. doi: 10.1016/j.jacc.2011.06.024. J Am Coll Cardiol. 2011. PMID: 21920268 Review.
-
Erectile dysfunction and cardiovascular disease.Postgrad Med. 2011 May;123(3):7-16. doi: 10.3810/pgm.2011.05.2279. Postgrad Med. 2011. PMID: 21566411 Review.
Cited by
-
Does vitamin D deficiency contribute to erectile dysfunction?Dermatoendocrinol. 2012 Apr 1;4(2):128-36. doi: 10.4161/derm.20361. Dermatoendocrinol. 2012. PMID: 22928068 Free PMC article.
-
Prevalence of sexual dysfunction and pursuit of sexual medicine evaluation among male physicians-a survey.Int J Impot Res. 2024 Dec;36(8):854-857. doi: 10.1038/s41443-024-00827-4. Epub 2024 Jan 20. Int J Impot Res. 2024. PMID: 38245626
-
Cardiovascular autonomic neuropathy, erectile dysfunction and lower urinary tract symptoms in men with type 1 diabetes: findings from the DCCT/EDIC.J Urol. 2015 Jun;193(6):2045-51. doi: 10.1016/j.juro.2014.12.097. Epub 2015 Jan 10. J Urol. 2015. PMID: 25584994 Free PMC article. Clinical Trial.
-
Canadian Urological Association guideline: Erectile dysfunction.Can Urol Assoc J. 2021 Oct;15(10):310-322. doi: 10.5489/cuaj.7572. Can Urol Assoc J. 2021. PMID: 34665713 Free PMC article.
-
The role of radionuclide myocardial perfusion imaging for asymptomatic individuals.J Nucl Cardiol. 2011 Feb;18(1):3-15. doi: 10.1007/s12350-010-9320-5. J Nucl Cardiol. 2011. PMID: 21181519 No abstract available.
References
-
- Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007;120:151–157. - PubMed
-
- Aytaç IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999;84:50–56. - PubMed
-
- Billups KL. Sexual dysfunction and cardiovascular disease: integrative concepts and strategies. Am J Cardiol. 2005;96:57M–61M. - PubMed
-
- Billups KL, Bank AJ, Padma-Nathan H, Katz SD, Williams RA. Erectile dysfunction as a harbinger for increased cardiometabolic risk. Int J Impot Res. 2008;20:236–242. - PubMed
-
- Greenstein A, Chen J, Miller H, Matzkin H, Villa Y, Braf Z. Does severity of ischemic coronary disease correlate with erectile function? Int J Impot Res. 1997;9:123–126. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical